Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer
Abstract
:1. Introduction
2. Conventional Treatments of Breast Cancer
3. Photodynamic Therapy
3.1. Mechanism of Action
3.2. Photosensitizers
4. Metal Nanoparticles
5. Metal Nanoparticles and PDT
6. Combination of PDT with Other Therapies
6.1. PDT Combined with Chemotherapy
6.2. PDT Combined with Immunotherapy
6.3. PDT Combined with Targeted Therapy
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
- Goss, P.E.; Lee, B.L.; Badovinac-Crnjevic, T.; Strasser-Weippl, K.; Chavarri-Guerra, Y.; St Louis, J.; Villarreal-Garza, C.; Unger-Saldaña, K.; Ferreyra, M.; Debiasi, M.; et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013, 14, 391–436. [Google Scholar] [CrossRef]
- Marks, C.E.; Ren, Y.; Rosenberger, L.H.; Thomas, S.M.; Greenup, R.A.; Fayanju, O.M.; McDuff, S.; Kimmick, G.; Hwang, E.S.; Plichta, J.K. Surgical Management of the Axilla in Elderly Women with Node-Positive Breast Cancer. J. Surg. Res. 2020, 254, 275–285. [Google Scholar] [CrossRef]
- Balasubramanian, R.; Morgan, C.; Shaari, E.; Kovacs, T.; Pinder, S.E.; Hamed, H.; Sever, A.R.; Kothari, A. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Eur. J. Surg. Oncol. 2020, 46, 1028–1033. [Google Scholar] [CrossRef]
- Arenas, M.; Fernández-Arroyo, S.; Rodríguez-Tomàs, E.; Sabater, S.; Murria, Y.; Gascón, M.; Amillano, K.; Melé, M.; Camps, J.; Joven, J. Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy. Clin. Transl. Oncol. 2020, 22, 1078–1085. [Google Scholar] [CrossRef]
- Musgrove, E.A.; Sutherland, R.L. Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 2009, 9, 631–643. [Google Scholar] [CrossRef]
- Burande, A.S.; Viswanadh, M.K.; Jha, A.; Mehata, A.K.; Shaik, A.; Agrawal, N.; Poddar, S.; Mahto, S.K.; Muthu, M.S. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer. AAPS PharmSciTech 2020, 21, 151. [Google Scholar] [CrossRef]
- Tryfonidis, K.; Zardavas, D.; Katzenellenbogen, B.S.; Piccart, M. Endocrine treatment in breast cancer: Cure, resistance and beyond. Cancer Treat. Rev. 2016, 50, 68–81. [Google Scholar] [CrossRef] [PubMed]
- Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; et al. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 2011, 61, 250–281. [Google Scholar] [CrossRef] [PubMed]
- Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1, 279–293. [Google Scholar] [CrossRef] [Green Version]
- Luo, D.; Carter, K.A.; Miranda, D.; Lovell, J.F. Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv. Sci. 2017, 4, 1600106. [Google Scholar] [CrossRef] [Green Version]
- Preise, D.; Scherz, A.; Salomon, Y. Antitumor immunity promoted by vascular occluding therapy: Lessons from vascular-targeted photodynamic therapy (VTP). Photochem. Photobiol. Sci. 2011, 10, 681–688. [Google Scholar] [CrossRef]
- Donohoe, C.; Senge, M.O.; Arnaut, L.G.; Gomes-da-Silva, L.C. Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity. Biochim. Biophys. Acta Rev. Cancer 2019, 1872, 188308. [Google Scholar] [CrossRef] [PubMed]
- Ethirajan, M.; Chen, Y.; Joshi, P.; Pandey, R.K. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem. Soc. Rev. 2011, 40, 340–362. [Google Scholar] [CrossRef] [PubMed]
- Ming, L.; Cheng, K.; Chen, Y.; Yang, R.; Chen, D. Enhancement of tumor lethality of ROS in photodynamic therapy. Cancer Med. 2021, 10, 257–268. [Google Scholar] [CrossRef] [PubMed]
- Keene, J.P.; Kessel, D.; Land, E.J.; Redmond, R.W.; Truscott, T.G. Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds. Photochem. Photobiol. 1986, 43, 117–120. [Google Scholar] [CrossRef] [PubMed]
- Kessel, D. Photodynamic therapy: Apoptosis, paraptosis and beyond. Apoptosis 2020, 25, 611–615. [Google Scholar] [CrossRef]
- Bayda, S.; Adeel, M.; Tuccinardi, T.; Cordani, M.; Rizzolio, F. The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine. Molecules 2019, 25, 112. [Google Scholar] [CrossRef] [Green Version]
- Song, W.; Anselmo, A.C.; Huang, L. Nanotechnology intervention of the microbiome for cancer therapy. Nat. Nanotechnol. 2019, 14, 1093–1103. [Google Scholar] [CrossRef]
- Grodzinski, P.; Silver, M.; Molnar, L.K. Nanotechnology for cancer diagnostics: Promises and challenges. Expert Rev. Mol. Diagn. 2006, 6, 307–318. [Google Scholar] [CrossRef]
- Yezhelyev, M.; Yacoub, R.; O’Regan, R. Inorganic nanoparticles for predictive oncology of breast cancer. Nanomedicine 2009, 4, 83–103. [Google Scholar] [CrossRef]
- Cheng, S.H.; Lo, L.W. Inorganic nanoparticles for enhanced photodynamic cancer therapy. Curr. Drug Discov. Technol. 2011, 8, 250–268. [Google Scholar] [CrossRef]
- Montaseri, H.; Kruger, C.A.; Abrahamse, H. Inorganic Nanoparticles Applied for Active Targeted Photodynamic Therapy of Breast Cancer. Pharmaceutics 2021, 13, 296. [Google Scholar] [CrossRef]
- Derycke, A.S.; de Witte, P.A. Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 2004, 56, 17–30. [Google Scholar] [CrossRef]
- Banerjee, S.M.; MacRobert, A.J.; Mosse, C.A.; Periera, B.; Bown, S.G.; Keshtgar, M.R.S. Photodynamic therapy: Inception to application in breast cancer. Breast 2017, 31, 105–113. [Google Scholar] [CrossRef] [Green Version]
- Vlastos, G.; Verkooijen, H.M. Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. Oncologist 2007, 12, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Mastrangelopoulou, M.; Grigalavicius, M.; Berg, K.; Ménard, M.; Theodossiou, T.A. Cytotoxic and Photocytotoxic Effects of Cercosporin on Human Tumor Cell Lines. Photochem. Photobiol. 2019, 95, 387–396. [Google Scholar] [CrossRef] [Green Version]
- Abrahamse, H.; Hamblin, M.R. New photosensitizers for photodynamic therapy. Biochem. J. 2016, 473, 347–364. [Google Scholar] [CrossRef] [Green Version]
- Lee, C.N.; Hsu, R.; Chen, H.; Wong, T.W. Daylight Photodynamic Therapy: An Update. Molecules 2020, 25, 5195. [Google Scholar] [CrossRef] [PubMed]
- Debele, T.A.; Peng, S.; Tsai, H.C. Drug Carrier for Photodynamic Cancer Therapy. Int. J. Mol. Sci. 2015, 16, 22094–22136. [Google Scholar] [CrossRef] [PubMed]
- Portilho, F.A.; Cavalcanti, C.E.; Miranda-Vilela, A.L.; Estevanato, L.L.; Longo, J.P.; Santos, M.D.; Bocca, A.L.; Martins, O.P.; Simioni, A.R.; Morais, P.C.; et al. Antitumor activity of photodynamic therapy performed with nanospheres containing zinc-phthalocyanine. J. Nanobiotechnol. 2013, 11, 41. [Google Scholar] [CrossRef] [Green Version]
- Wan, M.T.; Lin, J.Y. Current evidence and applications of photodynamic therapy in dermatology. Clin. Cosmet. Investig. Dermatol. 2014, 7, 145–163. [Google Scholar]
- Hou, Y.J.; Yang, X.X.; Liu, R.Q.; Zhao, D.; Guo, C.X.; Zhu, A.C.; Wen, M.N.; Liu, Z.; Qu, G.F.; Meng, H.X. Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles. Int. J. Nanomed. 2020, 15, 6827–6838. [Google Scholar] [CrossRef]
- Baptista, M.S.; Cadet, J.; Di Mascio, P.; Ghogare, A.A.; Greer, A.; Hamblin, M.R.; Lorente, C.; Nunez, S.C.; Ribeiro, M.S.; Thomas, A.H.; et al. Type I and Type II Photosensitized Oxidation Reactions: Guidelines and Mechanistic Pathways. Photochem. Photobiol. 2017, 93, 912–919. [Google Scholar] [CrossRef] [Green Version]
- Postiglione, I.; Chiaviello, A.; Palumbo, G. Enhancing photodynamyc therapy efficacy by combination therapy: Dated, current and oncoming strategies. Cancers 2011, 3, 2597–2629. [Google Scholar] [CrossRef] [PubMed]
- Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2005, 2, 1–23. [Google Scholar] [CrossRef] [Green Version]
- Hwang, H.S.; Shin, H.; Han, J.; Na, K. Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J. Pharm. Investig. 2018, 48, 143–151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Buytaert, E.; Dewaele, M.; Agostinis, P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 2007, 1776, 86–107. [Google Scholar] [CrossRef]
- Mehraban, N.; Freeman, H.S. Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxygen Production. Materials 2015, 8, 4421–4456. [Google Scholar] [CrossRef]
- Reginato, E.; Wolf, P.; Hamblin, M.R. Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J. Immunol. 2014, 4, 1–11. [Google Scholar] [CrossRef]
- Yang, M.; Li, J.; Gu, P.; Fan, X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact. Mater. 2021, 6, 1973–1987. [Google Scholar] [CrossRef]
- Alsaab, H.O.; Alghamdi, M.S.; Alotaibi, A.S.; Alzhrani, R.; Alwuthaynani, F.; Althobaiti, Y.S.; Almalki, A.H.; Sau, S.; Iyer, A.K. Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine. Cancers 2020, 12, 2793. [Google Scholar] [CrossRef] [PubMed]
- Navarro-Triviño, F.J.; Ayén-Rodríguez, Á.; Llamas-Molina, J.M.; Saenz-Guirado, S.; Ruiz-Villaverde, R. Treatment of superficial basal cell carcinoma with 7.8% 5-aminolaevulinic acid nanoemulsion-based gel (BF-200 ALA) and photodynamic therapy: Results in clinical practice in a tertiary hospital. Dermatol. Ther. 2021, 34, e14558. [Google Scholar] [CrossRef] [PubMed]
- Josefsen, L.B.; Boyle, R.W. Photodynamic therapy and the development of metal-based photosensitisers. Met.-Based Drugs 2008, 2008, 276109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berg, K.; Selbo, P.K.; Weyergang, A.; Dietze, A.; Prasmickaite, L.; Bonsted, A.; Engesaeter, B.; Angell-Petersen, E.; Warloe, T.; Frandsen, N.; et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J. Microsc. 2005, 218, 133–147. [Google Scholar] [CrossRef]
- Davila, M.L. Photodynamic therapy. Gastrointest. Endosc. Clin. N. Am. 2011, 21, 67–79. [Google Scholar] [CrossRef]
- Dougherty, T.J.; Cooper, M.T.; Mang, T.S. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med. 1990, 10, 485–488. [Google Scholar] [CrossRef]
- Chatterjee, D.K.; Fong, L.S.; Zhang, Y. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60, 1627–1637. [Google Scholar] [CrossRef] [PubMed]
- Zhang, J.; Jiang, C.; Figueiró Longo, J.P.; Azevedo, R.B.; Zhang, H.; Muehlmann, L.A. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm. Sin. B 2018, 8, 137–146. [Google Scholar] [CrossRef]
- Uyguner Demirel, C.S.; Birben, N.C.; Bekbolet, M. A comprehensive review on the use of second generation TiO(2) photocatalysts: Microorganism inactivation. Chemosphere 2018, 211, 420–448. [Google Scholar] [CrossRef]
- Klajnert, B.; Rozanek, M.; Bryszewska, M. Dendrimers in photodynamic therapy. Curr. Med. Chem. 2012, 19, 4903–4912. [Google Scholar] [CrossRef]
- Roguin, L.P.; Chiarante, N.; García Vior, M.C.; Marino, J. Zinc (II) phthalocyanines as photosensitizers for antitumor photodynamic therapy. Int. J. Biochem. Cell Biol. 2019, 114, 105575. [Google Scholar] [CrossRef]
- Fabris, C.; Soncin, M.; Miotto, G.; Fantetti, L.; Chiti, G.; Dei, D.; Roncucci, G.; Jori, G. Zn (II)-phthalocyanines as phototherapeutic agents for cutaneous diseases. Photosensitization of fibroblasts and keratinocytes. J. Photochem. Photobiol. B Biol. 2006, 83, 48–54. [Google Scholar] [CrossRef] [PubMed]
- Mantareva, V.; Kussovski, V.; Angelov, I.; Borisova, E.; Avramov, L.; Schnurpfeil, G.; Wöhrle, D. Photodynamic activity of water-soluble phthalocyanine zinc (II) complexes against pathogenic microorganisms. Bioorg. Med. Chem. 2007, 15, 4829–4835. [Google Scholar] [CrossRef]
- Tynga, I.M.; Houreld, N.N.; Abrahamse, H. The primary subcellular localization of Zinc phthalocyanine and its cellular impact on viability, proliferation and structure of breast cancer cells (MCF-7). J. Photochem. Photobiol. B Biol. 2013, 120, 171–176. [Google Scholar] [CrossRef] [PubMed]
- Mfouo-Tynga, I.; Houreld, N.N.; Abrahamse, H. Induced cell death pathway post photodynamic therapy using a metallophthalocyanine photosensitizer in breast cancer cells. Photomed. Laser Surg. 2014, 32, 205–211. [Google Scholar] [CrossRef]
- Chen, H.; Tian, J.; He, W.; Guo, Z. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells. J. Am. Chem. Soc. 2015, 137, 1539–1547. [Google Scholar] [CrossRef]
- Qian, C.; Yu, J.; Chen, Y.; Hu, Q.; Xiao, X.; Sun, W.; Wang, C.; Feng, P.; Shen, Q.D.; Gu, Z. Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy. Adv. Mater. 2016, 28, 3313–3320. [Google Scholar] [CrossRef]
- Castano, A.P.; Mroz, P.; Wu, M.X.; Hamblin, M.R. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc. Natl. Acad. Sci. USA 2008, 105, 5495–5500. [Google Scholar] [CrossRef] [Green Version]
- Kataoka, H.; Nishie, H.; Hayashi, N.; Tanaka, M.; Nomoto, A.; Yano, S.; Joh, T. New photodynamic therapy with next-generation photosensitizers. Ann. Transl. Med. 2017, 5, 183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Doroudian, M.; O’Neill, A.; Mac Loughlin, R.; Prina-Mello, A.; Volkov, Y.; Donnelly, S.C. Nanotechnology in pulmonary medicine. Curr. Opin. Pharmacol. 2021, 56, 85–92. [Google Scholar] [CrossRef]
- Bockamp, E.; Rosigkeit, S.; Siegl, D.; Schuppan, D. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology. Cells 2020, 9, 2102. [Google Scholar] [CrossRef]
- Wang, Y.; Zhang, P.; Wei, Y.; Shen, K.; Xiao, L.; Miron, R.J.; Zhang, Y. Cell-Membrane-Display Nanotechnology. Adv. Healthc. Mater. 2021, 10, e2001014. [Google Scholar] [CrossRef] [PubMed]
- Liu, N. DNA Nanotechnology Meets Nanophotonics. Nano Lett. 2020, 20, 8430–8431. [Google Scholar] [CrossRef] [PubMed]
- Giakoumettis, D.; Sgouros, S. Nanotechnology in neurosurgery: A systematic review. Child’s Nerv. Syst. 2021, 37, 1045–1054. [Google Scholar] [CrossRef]
- Jain, V.; Kumar, H.; Anod, H.V.; Chand, P.; Gupta, N.V.; Dey, S.; Kesharwani, S.S. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J. Control. Release 2020, 326, 628–647. [Google Scholar] [CrossRef] [PubMed]
- Lee, P.Y.; Wong, K.K. Nanomedicine: A new frontier in cancer therapeutics. Curr. Drug Deliv. 2011, 8, 245–253. [Google Scholar]
- Seigneuric, R.; Markey, L.; Nuyten, D.S.; Dubernet, C.; Evelo, C.T.; Finot, E.; Garrido, C. From nanotechnology to nanomedicine: Applications to cancer research. Curr. Mol. Med. 2010, 10, 640–652. [Google Scholar] [CrossRef]
- Aufderhorst-Roberts, A.; Baker, D.; Foster, R.J.; Cayre, O.; Mattsson, J.; Connell, S.D. Nanoscale mechanics of microgel particles. Nanoscale 2018, 10, 16050–16061. [Google Scholar] [CrossRef] [Green Version]
- Chandler, M.; Minevich, B.; Roark, B.; Viard, M.; Johnson, M.B.; Rizvi, M.H.; Deaton, T.A.; Kozlov, S.; Panigaj, M.; Tracy, J.B.; et al. Controlled Organization of Inorganic Materials Using Biological Molecules for Activating Therapeutic Functionalities. ACS Appl. Mater. Interfaces 2021, 13, 39030–39041. [Google Scholar] [CrossRef]
- Hoshyar, N.; Gray, S.; Han, H.; Bao, G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 2016, 11, 673–692. [Google Scholar] [CrossRef] [Green Version]
- Pridgen, E.M.; Langer, R.; Farokhzad, O.C. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2007, 2, 669–680. [Google Scholar] [CrossRef]
- Fu, Z.; Xiang, J. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. Int. J. Mol. Sci. 2020, 21, 9123. [Google Scholar] [CrossRef]
- Zhao, P.; Wang, M.; Chen, M.; Chen, Z.; Peng, X.; Zhou, F.; Song, J.; Qu, J. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials 2020, 254, 120142. [Google Scholar] [CrossRef] [PubMed]
- Chouikrat, R.; Seve, A.; Vanderesse, R.; Benachour, H.; Barberi-Heyob, M.; Richeter, S.; Raehm, L.; Durand, J.O.; Verelst, M.; Frochot, C. Non polymeric nanoparticles for photodynamic therapy applications: Recent developments. Curr. Med. Chem. 2012, 19, 781–792. [Google Scholar] [CrossRef] [PubMed]
- Calixto, G.M.; Bernegossi, J.; de Freitas, L.M.; Fontana, C.R.; Chorilli, M. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules 2016, 21, 342. [Google Scholar] [CrossRef]
- Zhang, X.Y.; Zhang, P.Y. Nanotechnology for multimodality treatment of cancer. Oncol. Lett. 2020, 20, 237. [Google Scholar] [CrossRef] [PubMed]
- Svenskaya, Y.; Parakhonskiy, B.; Haase, A.; Atkin, V.; Lukyanets, E.; Gorin, D.; Antolini, R. Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer. Biophys. Chem. 2013, 182, 11–15. [Google Scholar] [CrossRef] [Green Version]
- Tharkar, P.; Madani, A.U.; Lasham, A.; Shelling, A.N.; Al-Kassas, R. Nanoparticulate carriers: An emerging tool for breast cancer therapy. J. Drug Target. 2015, 23, 97–108. [Google Scholar] [CrossRef] [PubMed]
- Song, Y.; Wang, L.; Xie, Z. Metal-Organic Frameworks for Photodynamic Therapy: Emerging Synergistic Cancer Therapy. Biotechnol. J. 2021, 16, e1900382. [Google Scholar] [CrossRef]
- Lee, J.; Chatterjee, D.K.; Lee, M.H.; Krishnan, S. Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Lett. 2014, 347, 46–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turkevich, J.; Stevenson, P.C.; Hillier, J. A Study of the Nucleation and Growth Processes in the Synthesis of Colloidal Gold. Discuss. Faraday Soc. 1951, 11, 55. [Google Scholar] [CrossRef]
- Frens, G. Controlled Nucleation for Regulation of Particle-Size In Monodisperse Gold Suspensions. Nat. Phys. Sci. 1973, 241, 20–22. [Google Scholar] [CrossRef]
- Bastús, N.G.; Sanchez-Tillo, E.; Pujals, S.; Farrera, C.; Lopez, C.; Giralt, E.; Celada, A.; Lloberas, J.; Puntes, V. Homogeneous Conjugation of Peptides onto Gold Nanoparticles Enhances Macrophage Response. ACS Nano 2009, 3, 1335–1344. [Google Scholar] [CrossRef]
- Kogan, M.J.; Bastús, N.G.; Amigo, R.; Grillo-Bosch, D.; Araya, E.; Turiel, A.; Labarta, A.; Giralt, E.; Puntes, V.F. Nanoparticlemediated Local and Remote Manipulation of Protein Aggregation. Nano Lett. 2006, 6, 110–115. [Google Scholar] [CrossRef]
- Ji, X.; Song, X.; Li, J.; Bai, Y.; Yang, W.; Peng, X. Size control of gold nanocrystals in citrate reduction: The third role of citrate. J. Am. Chem. Soc. 2007, 129, 13939–13948. [Google Scholar] [CrossRef]
- Schulz, F.; Homolka, T.; Bastús, N.G.; Puntes, V.; Weller, H.; Vossmeyer, T. Little Adjustments Significantly Improve the Turkevich Synthesis of Gold Nanoparticles. Langmuir 2014, 30, 10779. [Google Scholar] [CrossRef]
- Jordi, P.; Neus, G.B.; Victor, P. Size-Controlled Synthesis of Sub-10-nanometer Citrate-Stabilized Gold Nanoparticles and Related Optical Properties. ACS Nano 2016, 28, 1066–1075. [Google Scholar]
- Sau, T.K.; Murphy, C.J. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir 2004, 20, 6414–6420. [Google Scholar] [CrossRef]
- Babak, N.; Mostafa, A.E. Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method. ACS Nano 2003, 15, 1957–1962. [Google Scholar]
- Robert, C.W.; Laura, F.; Richard, A.V.; Kyoungweon, P. Time-Dependent Susceptibility of the Growth of Gold Nanorods to the Addition of a Cosurfactant. ACS Nano 2013, 25, 4772–4780. [Google Scholar]
- Matthew, J.W.; Karen, J.E.; Adrian, M.H.; James, A.H.; Gareth, J.P. Control of mesostructured in self-assembled polymer/surfactant films by rational micelle design. Soft Matter. 2012, 8, 3357–3362. [Google Scholar]
- Liu, K.; Zheng, Y.H.; Lu, X.; Thai, T.; Lee, N.A.; Bach, U.; Gooding, J.J. Biocompatible gold nanorods: One-step surface functionalization, highly colloidal stability, and low cytotoxicity. Langmuir 2015, 31, 4973–4980. [Google Scholar] [CrossRef] [PubMed]
- Oldenburg, S.J.; Averitt, R.D.; Westcott, S.L.; Halas, N.J. Nanoengineering of optical resonances. Chem. Phys. Lett. 1998, 288, 243–247. [Google Scholar] [CrossRef]
- Zhao, J.; Wallace, M.; Melancon, M.P. Cancer theranostics with gold nanoshells. Nanomedicine 2014, 9, 2041–2057. [Google Scholar] [CrossRef] [PubMed]
- You, J.; Zhang, R.; Xiong, C.; Zhong, M.; Melancon, M.; Gupta, S.; Nick, A.M.; Sood, A.K.; Li, C. Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res. 2012, 72, 4777–4786. [Google Scholar] [CrossRef] [Green Version]
- Hinshaw, D.C.; Shevde, L.A. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019, 79, 4557–4566. [Google Scholar] [CrossRef] [Green Version]
- Fan, W.; Huang, P.; Chen, X. Overcoming the Achilles’ heel of photodynamic therapy. Chem. Soc. Rev. 2016, 45, 6488–6519. [Google Scholar] [CrossRef]
- Cole, A.J.; Yang, V.C.; David, A.E. Cancer theranostics: The rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011, 29, 323–332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gautier, J.; Allard-Vannier, E.; Munnier, E.; Soucé, M.; Chourpa, I. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. J. Control. Release 2013, 169, 48–61. [Google Scholar] [CrossRef]
- Khan, M.S.; Vishakante, G.D.; Siddaramaiah, H. Gold nanoparticles: A paradigm shift in biomedical applications. Adv. Colloid Interface Sci. 2013, 199–200, 44–58. [Google Scholar] [CrossRef]
- Li, J.; Gupta, S.; Li, C. Research perspectives: Gold nanoparticles in cancer theranostics. Quant. Imaging Med. Surg. 2013, 3, 284–291. [Google Scholar]
- Yoon, I.; Li, J.Z.; Shim, Y.K. Advance in photosensitizers and light delivery for photodynamic therapy. Clin. Endosc. 2013, 46, 7–23. [Google Scholar] [CrossRef]
- Mokoena, D.R.; George, B.P.; Abrahamse, H. Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy. Int. J. Mol. Sci. 2019, 20, 4771. [Google Scholar] [CrossRef] [Green Version]
- Lin, L.; Xiong, L.; Wen, Y.; Lei, S.; Deng, X.; Liu, Z.; Chen, W.; Miao, X. Active Targeting of Nano-Photosensitizer Delivery Systems for Photodynamic Therapy of Cancer Stem Cells. J. Biomed. Nanotechnol. 2015, 11, 531–554. [Google Scholar] [CrossRef] [PubMed]
- Zhou, T.J.; Xing, L.; Fan, Y.T.; Cui, P.F.; Jiang, H.L. Inhibition of breast cancer proliferation and metastasis by strengthening host immunity with a prolonged oxygen-generating phototherapy hydrogel. J. Control. Release 2019, 309, 82–93. [Google Scholar] [CrossRef] [PubMed]
- Lee, K.E. Do all patients with breast cancer benefit from neoadjuvant chemotherapy? Korean J. Int. Med. 2020, 35, 1336–1337. [Google Scholar] [CrossRef] [PubMed]
- Hauner, K.; Maisch, P.; Retz, M. Side effects of chemotherapy. Urol. Ausg. A 2017, 56, 472–479. [Google Scholar] [CrossRef]
- El-Hussein, A.; Manoto, S.L.; Ombinda-Lemboumba, S.; Alrowaili, Z.A.; Mthunzi-Kufa, P. A Review of Chemotherapy and Photodynamic Therapy for Lung Cancer Treatment. Anti-Cancer Agents Med. Chem. 2021, 21, 149–161. [Google Scholar] [CrossRef]
- Fanciullino, R.; Ciccolini, J.; Milano, G. Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs. Crit. Rev. Oncol./Hematol. 2013, 88, 504–513. [Google Scholar] [CrossRef]
- Kuchur, O.A.; Tsymbal, S.A.; Shestovskaya, M.V.; Serov, N.S.; Dukhinova, M.S.; Shtil, A.A. Metal-derived nanoparticles in tumor theranostics: Potential and limitations. J. Inorg. Biochem. 2020, 209, 111117. [Google Scholar] [CrossRef] [PubMed]
- Guarino-Hotz, M.; Zhang, J.Z. Structural control and biomedical applications of plasmonic hollow gold nanospheres: A mini review. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2021, 13, e1694. [Google Scholar] [CrossRef] [PubMed]
- Imanparast, A.; Bakhshizadeh, M.; Salek, R.; Sazgarnia, A. Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells. Photodiagn. Photodyn. Ther. 2018, 23, 295–305. [Google Scholar] [CrossRef] [PubMed]
- Zhang, L.; Gao, Y.; Sun, S.; Li, Z.; Wu, A.; Zeng, L. pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer. J. Mater. Chem. B 2020, 8, 1739–1747. [Google Scholar] [CrossRef]
- Xu, W.; Qian, J.; Hou, G.; Wang, Y.; Wang, J.; Sun, T.; Ji, L.; Suo, A.; Yao, Y. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. Acta Biomater. 2018, 82, 171–183. [Google Scholar] [CrossRef]
- Sharma, P.; Wagner, K.; Wolchok, J.D.; Allison, J.P. Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps. Nat. Rev. Cancer 2011, 11, 805–812. [Google Scholar] [CrossRef] [PubMed]
- Esfahani, K.; Roudaia, L.; Buhlaiga, N.; Del Rincon, S.V.; Papneja, N.; Miller, W.H., Jr. A review of cancer immunotherapy: From the past, to the present, to the future. Curr. Oncol. 2020, 27, S87–S97. [Google Scholar] [CrossRef]
- Sanmamed, M.F.; Chen, L. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization. Cell 2018, 175, 313–326. [Google Scholar] [CrossRef] [Green Version]
- Rooney, M.S.; Shukla, S.A.; Wu, C.J.; Getz, G.; Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 2015, 160, 48–61. [Google Scholar] [CrossRef] [Green Version]
- Kousis, P.C.; Henderson, B.W.; Maier, P.G.; Gollnick, S.O. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res. 2007, 67, 10501–10510. [Google Scholar] [CrossRef] [Green Version]
- Hou, X.; Tao, Y.; Pang, Y.; Li, X.; Jiang, G.; Liu, Y. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int. J. Cancer 2018, 143, 3050–3060. [Google Scholar] [CrossRef] [Green Version]
- Zhang, X.; Tang, J.; Li, C.; Lu, Y.; Cheng, L.; Liu, J. A targeting black phosphorus nanoparticle based immune cells nano-regulator for photodynamic/photothermal and photo-immunotherapy. Bioact. Mater. 2021, 6, 472–489. [Google Scholar] [CrossRef] [PubMed]
- Yang, C.; Fu, Y.; Huang, C.; Hu, D.; Zhou, K.; Hao, Y.; Chu, B.; Yang, Y.; Qian, Z. Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy. Biomaterials 2020, 255, 120194. [Google Scholar] [CrossRef] [PubMed]
- Wu, X.; Yang, H.; Chen, X.; Gao, J.; Duan, Y.; Wei, D.; Zhang, J.; Ge, K.; Liang, X.J.; Huang, Y.; et al. Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment. Biomaterials 2021, 269, 120654. [Google Scholar] [CrossRef] [PubMed]
- Yao, X.; Yang, B.; Wang, S.; Dai, Z.; Zhang, D.; Zheng, X.; Liu, Q. A novel multifunctional FePt/BP nanoplatform for synergistic photothermal/photodynamic/chemodynamic cancer therapies and photothermally-enhanced immunotherapy. J. Mater. Chem. B 2020, 8, 8010–8021. [Google Scholar] [CrossRef]
- Duan, X.; Chan, C.; Guo, N.; Han, W.; Weichselbaum, R.R.; Lin, W. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade to Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. J. Am. Chem. Soc. 2016, 138, 16686–16695. [Google Scholar] [CrossRef] [Green Version]
- Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 2010, 148, 135–146. [Google Scholar] [CrossRef]
- Kruger, C.A.; Abrahamse, H. Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy. Molecules 2018, 23, 2628. [Google Scholar] [CrossRef] [Green Version]
- Kim, E.H.; Park, S.; Kim, Y.K.; Moon, M.; Park, J.; Lee, K.J.; Lee, S.; Kim, Y.P. Self-luminescent photodynamic therapy using breast cancer targeted proteins. Sci. Adv. 2020, 6, 37. [Google Scholar] [CrossRef]
- Liang, S.; Sun, M.; Lu, Y.; Shi, S.; Yang, Y.; Lin, Y.; Feng, C.; Liu, J.; Dong, C. Cytokine-induced killer cells-assisted tumor-targeting delivery of Her-2 monoclonal antibody-conjugated gold nanostars with NIR photosensitizer for enhanced therapy of cancer. J. Mater. Chem. B 2020, 8, 8368–8382. [Google Scholar] [CrossRef]
- He, Z.; Jiang, H.; Zhang, X.; Zhang, H.; Cui, Z.; Sun, L.; Li, H.; Qian, J.; Ma, J.; Huang, J. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer. Pharmacol. Res. 2020, 160, 105184. [Google Scholar] [CrossRef]
- Xu, W.; Qian, J.; Hou, G.; Wang, Y.; Wang, J.; Sun, T.; Ji, L.; Suo, A.; Yao, Y. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer. Acta Biomater. 2019, 83, 400–413. [Google Scholar] [CrossRef]
- Akbarzadeh, A.; Samiei, M.; Davaran, S. Magnetic nanoparticles: Preparation, physical properties, and applications in biomedicine. Nanoscale Res. Lett. 2012, 7, 144. [Google Scholar] [CrossRef] [Green Version]
- Grancharov, S.G.; Zeng, H.; Sun, S.; Wang, S.X.; O’Brien, S.; Murray, C.B.; Kirtley, J.R.; Held, G.A. Bio-functionalization of monodisperse magnetic nanoparticles and their use as biomolecular labels in a magnetic tunnel junction based sensor. J. Phys. Chem. B 2005, 109, 13030–13035. [Google Scholar] [CrossRef] [Green Version]
- Piao, Y.; Kim, J.; Na, H.B.; Kim, D.; Baek, J.S.; Ko, M.K.; Lee, J.H.; Shokouhimehr, M.; Hyeon, T. Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat. Mater. 2008, 7, 242–247. [Google Scholar] [CrossRef]
- Matlou, G.G.; Oluwole, D.O.; Prinsloo, E.; Nyokong, T. Photodynamic therapy activity of zinc phthalocyanine linked to folic acid and magnetic nanoparticles. J. Photochem. Photobiol. B Biol. 2018, 186, 216–224. [Google Scholar] [CrossRef]
- Feng, Y.; Wu, Y.; Zuo, J.; Tu, L.; Que, I.; Chang, Y.; Cruz, L.J.; Chan, A.; Zhang, H. Assembly of upconversion nanophotosensitizer in vivo to achieve scatheless real-time imaging and selective photodynamic therapy. Biomaterials 2019, 201, 33–41. [Google Scholar] [CrossRef] [PubMed]
- Karrison, T.G.; Ferguson, D.J.; Meier, P. Dormancy of mammary carcinoma after mastectomy. J. Natl. Cancer Inst. 1999, 91, 80–85. [Google Scholar] [CrossRef]
- Maham, A.; Tang, Z.; Wu, H.; Wang, J.; Lin, Y. Protein-based nanomedicine platforms for drug delivery. Small 2009, 5, 1706–1721. [Google Scholar] [CrossRef] [PubMed]
- Lucky, S.S.; Soo, K.C.; Zhang, Y. Nanoparticles in photodynamic therapy. Chem. Rev. 2015, 115, 1990–2042. [Google Scholar] [CrossRef]
- Zhang, T.; Bao, J.; Zhang, M.; Ge, Y.; Wei, J.; Li, Y.; Wang, W.; Li, M.; Jin, Y. Chemo-photodynamic therapy by pulmonary delivery of gefitinib nanoparticles and 5-aminolevulinic acid for treatment of primary lung cancer of rats. Photodiagn. Ther. 2020, 31, 101807. [Google Scholar] [CrossRef] [PubMed]
- Huang, J.; Xiao, Z.; An, Y.; Han, S.; Wu, W.; Wang, Y.; Guo, Y.; Shuai, X. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy. Biomaterials 2021, 269, 120636. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.Y.; Sharma, S.K.; Dai, T.; Chung, H.; Yaroslavsky, A.; Garcia-Diaz, M.; Chang, J.; Chiang, L.Y.; Hamblin, M.R. Can nanotechnology potentiate photodynamic therapy? Nanotechnol. Rev. 2012, 1, 111–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shang, L.; Zhou, X.; Zhang, J.; Shi, Y.; Zhong, L. Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer. Molecules 2021, 26, 6532. https://doi.org/10.3390/molecules26216532
Shang L, Zhou X, Zhang J, Shi Y, Zhong L. Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer. Molecules. 2021; 26(21):6532. https://doi.org/10.3390/molecules26216532
Chicago/Turabian StyleShang, Liang, Xinglu Zhou, Jiarui Zhang, Yujie Shi, and Lei Zhong. 2021. "Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer" Molecules 26, no. 21: 6532. https://doi.org/10.3390/molecules26216532